Atul Kumar

Atul Kumar is a synthetic organic chemist, Professor & Chief Scientist at the Academy of Scientific and Innovative Research (AcSIR) and Chairperson of Medicinal and Process Chemistry Division Central Drug Research Institute (CSIR-CDRI) at Lucknow, India and a Dean at National Institute of Pharmaceutical Education and Research, Raebareli.

Academic work Kumar has about 24 years experience in drug design, medicinal chemistry and Green Chemistry

Dr. Kumar's major contributions are the invention of anti-osteoporosis drug candidate CDRI-99/373 (CENTHANK), which is an currently in phase 1 clinical trial and NCE anti-cancer compound CDRI-S-007-1235, is currently in Pre-clinical stage.